Refinery has not recorded this company's share classes yet, so ownership cannot be shown across them.
| Class | Shares outstanding | Held by institutions | Votes a share | Economics a share |
|---|---|---|---|---|
| QNRX | — | — | 1 vote | 1 |
A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.
Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Quoin Pharmaceuticals Ltd. in the last 12 months.
There are not yet two fiscal years of reported share counts for Quoin Pharmaceuticals Ltd..
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DI
Dauntless Investment Group, LLC
|
215.0K | — | +18.4K (+9.4%) | Q1 '26 | 0.8% | |
|
Shares held by quarter
Peak holding215.0K (Q2'26)
Change over 8 quarters+215.0K
|
||||||
|
IC
Ikarian Capital, LLC
|
211.5K | — | Unchanged | Q4 '25 | 0.1% | |
|
Shares held by quarter
|
||||||
20 more super investors behind a free account
See every manager holding Quoin Pharmaceuticals Ltd., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
AW
abrdn World Healthcare Fund
abrdn World Healthcare Fund
|
$196K | 40.4K | — | 0.03% | June 30, 2026 |
|
AL
abrdn Life Sciences Investors
abrdn Life Sciences Investors
|
$167K | 34.6K | — | 0.02% | June 30, 2026 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DC
Denise Carter
5%+ holder
13D · 4.9%
|
939.2K | — | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
Disclosed stake13D · 4.9%
|
||||||
|
MM
Michael Myers
5%+ holder
13D · 4.9%
|
939.2K | — | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
Disclosed stake13D · 4.9%
|
||||||
Loading...